Cargando…

Predictive value of CHA(2)DS(2)VASC score for contrast-induced nephropathy after primary percutaneous coronary intervention for patients presenting with acute ST-segment elevation myocardial infarction

BACKGROUND: ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (pPCI) are at increased risk for contrast-induced nephropathy (CIN) than elective PCI procedures. Routine calculation of Mehran’s score is limited by its complexity and difficulty to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samir, Ahmad, Gabra, Wafik, Alhossary, Hossam, Bakhoum, Sameh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293538/ https://www.ncbi.nlm.nih.gov/pubmed/37358644 http://dx.doi.org/10.1186/s43044-023-00378-x

Ejemplares similares

Predictive value of CHA(2)DS(2)-VASc and CHA(2)DS(2)-VASc-HS scores for failed reperfusion after thrombolytic therapy in patients with ST-segment elevation myocardial infarction
por: Kilic, Salih, et al.
Publicado: (2019)

CHA2DS2-VASc score as a novel predictor for contrast-induced nephropathy after percutaneous coronary intervention in acute coronary syndrome
por: Chaudhary, Abhay Kumar, et al.
Publicado: (2019)

CHA(2)DS(2)-VASc: time to settle the score?
por: Kaplan, Rachel M., et al.
Publicado: (2022)

CHA(2)DS(2)-VASc and R(2)-CHA(2)DS(2)-VASc scores predict in-hospital and post-discharge outcome in patients with myocardial infarction
por: Węgiel, Michał, et al.
Publicado: (2018)

CHA(2)DS(2)-Vasc score and CHA(2)DS(2)-Vasc-HS score are poor predictors of in-stent restenosis among patients with coronary drug-eluting stents
por: Zhao, Sheng Gang, et al.
Publicado: (2019)

CHA2DS2-VASc score and modified CHA2DS2-VASc score can predict mortality and intensive care unit hospitalization in COVID-19 patients
por: Gunduz, Ramazan, et al.
Publicado: (2021)

The Impact of Lesion Complexity and the CHA(2)DS(2)-VASc Score on Spontaneous Reperfusion in Patients with ST-Segment Elevation Myocardial Infarction
por: Alıcı, Gökhan, et al.
Publicado: (2022)

Heart failure: a weak link in CHA(2)DS(2)‐VASc
por: Friberg, Leif, et al.
Publicado: (2018)

CHA(2)DS(2)-VASc Score in Cardio-Oncology: Sharpening the Rules
por: López-Fernández, Teresa
Publicado: (2023)

Association of CHA2DS2-VASC Score with in-Hospital Cardiovascular Adverse Events in Patients with Acute ST-Segment Elevation Myocardial Infarction
por: Fang, Caoyang, et al.
Publicado: (2022)

Better prediction of stroke in atrial fibrillation with incorporation of cancer in CHA(2)DS(2)VASC score: CCHA(2)DS(2)VASC score
por: Bungo, Brandon, et al.
Publicado: (2022)

New CHA(2)DS(2)-VASc-HSF score predicts the no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction
por: Zhang, Qin-Yao, et al.
Publicado: (2020)

Cheating the CHA(2)DS(2)-VASc Score: Thromboembolism in Apical Hypertrophic Cardiomyopathy
por: Weir, Robin A. P., et al.
Publicado: (2014)

Correlation between CHA(2)DS(2)-VASc Score and Glaucoma Treatment and Prognosis
por: Pikkel, Yoav Y., et al.
Publicado: (2018)

Beyond CHA(2)DS(2)-VASc in atrial fibrillation: the atrium and the risk of stroke
por: Boccanelli, Alessandro
Publicado: (2020)

Escore CHA2DS2-VASc: O Que Mais Podemos Predizer?
por: Maia, Adnaldo da Silveira
Publicado: (2023)

CHA2DS2-VASc Score Predict No-Reflow Phenomenon in Primary Percutaneous Coronary Intervention in Primary Percutaneous Coronary Intervention
por: Mirbolouk, Fardin, et al.
Publicado: (2018)

Left atrial spontaneous echo contrast occurring in patients with low CHADS(2) or CHA(2)DS(2)-VASc scores
por: Akamatsu, Kanako, et al.
Publicado: (2020)

Prognostic Impacts of CHADS(2), CHA(2)DS(2)-VASc, and CHA(2)DS(2)-VASc-HS Scores on Clinical Outcomes After Elective Drug-Eluting Stent Placement for De Novo Coronary Stenosis
por: Ukaji, Tomoaki, et al.
Publicado: (2023)

CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience
por: Wang, Yong, et al.
Publicado: (2019)

Value of the CHA(2)DS(2)‐VASc score for predicting outcome in patients with heart failure
por: Shuvy, Mony, et al.
Publicado: (2020)

Does CHA2DS2-VASc score predict mortality in chronic kidney disease?
por: Goudis, Christos, et al.
Publicado: (2021)

Stroke and systemic embolism risk in patients with CHA(2)DS(2)‐VASc score of 0
por: Babayiğit, Erdi, et al.
Publicado: (2023)

CHA(2)DS(2)-VASc score predicts the slow flow/no-reflow phenomenon in ST-segment elevation myocardial infarction patients with multivessel disease undergoing primary percutaneous coronary intervention
por: Huang, Xin, et al.
Publicado: (2021)

The CHA(2)DS(2)-VASc Score Predicts New-Onset Atrial Fibrillation and Hemodynamic Complications in Patients with ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention
por: Cozac, Dan Alexandru, et al.
Publicado: (2022)

Predictive value of CHA(2)DS(2)‐VASc score for in‐hospital prognosis of patients with acute ST‐segment elevation myocardial infarction undergoing primary PCI
por: Sun, Ying, et al.
Publicado: (2023)

CHA2DS2 VASc score and brachial artery flow-mediated dilation as predictors for no-reflow phenomenon in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Rashed, Mohamed Ismail, et al.
Publicado: (2022)

Prognostic value of GRACE and CHA2DS2-VASc score among patients with atrial fibrillation undergoing percutaneous coronary intervention
por: Guo, Tingting, et al.
Publicado: (2021)

New R(2)-CHA(2)DS(2)-VASc score predicts no-reflow phenomenon and long-term prognosis in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention
por: Zhang, Qinyao, et al.
Publicado: (2022)

High CHA(2)DS(2)-VASc score without atrial fibrillation: ‘NAO yes, NAO no’
por: Perna, Gian Piero
Publicado: (2019)

What should the C (‘congestive heart failure’) represent in the CHA(2)DS(2)‐VASc score?
por: Mulder, Bart A., et al.
Publicado: (2020)

CHA(2)DS(2)‐VASc Score and the Risk of Ventricular Tachyarrhythmic Events and Mortality in MADIT‐CRT
por: Nof, Eyal, et al.
Publicado: (2019)

CHA(2)DS(2)-VASc score stratifies mortality risk in patients with and without atrial fibrillation
por: Harb, Serge C, et al.
Publicado: (2021)

Predictive Value of CHA(2)DS(2) -VASc-HSF Score for Severity of Acute Coronary Syndrome
por: Liu, Jingyi, et al.
Publicado: (2022)

CHA(2)DS(2)-VASc score for in-hospital recurrence risk stratification in patients with myocardial infarction
por: Pang, Hui, et al.
Publicado: (2022)

Predictive value of CHADS(2) and CHA(2)DS(2)-VASc scores for coronary artery lesions and in-hospital prognosis of patients with acute ST-segment elevation myocardial infarction
por: Li, Xiaoli, et al.
Publicado: (2021)

R(2(GFR))CHADS(2) and R(2(GFR))CHA(2)DS(2)VASc schemes improved the performance of CHADS(2) and CHA(2)DS(2)VASc scores in death risk stratification of Chinese older patients with atrial fibrillation
por: Fu, Shihui, et al.
Publicado: (2017)

The impact of cigarette smoking in predicting stroke using CHADS(2) and CHA(2)DS(2)-VASc schemas
por: Zuo, Ming-Liang, et al.
Publicado: (2020)

Arterial Thromboembolism in Patients With AF and CHA(2)DS(2)-VASc Score 0-2 With and Without Cancer
por: Leader, Avi, et al.
Publicado: (2023)

CHA(2)DS(2)-VASc score as predictor of ischemic stroke in patients undergoing coronary artery bypass grafting and percutaneous coronary intervention
por: Tian, Yaohua, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fpr6r4hl2jrpa0feevbf18goqp